Screener

486 companies · every ratio sourced from the company's own NSE filing. Update the cache with python manage.py refresh_market_data. Looking to browse the whole universe instead of filtering it? See Browse all companies.

Metric names & syntax

ℹ A custom screen is a filter you defined. StockProof computes the metrics and reports which companies satisfy the condition you wrote — it does not assess, endorse or rank the strategy behind it, and a company appearing in these results is not a recommendation to buy or sell. Companies missing an input your formula needs are listed separately as “couldn't be judged”, never counted as non-matches.

Piotroski F-Score — 9-criteria profitability, leverage, and efficiency composite.

1 result Extract this table (respects filters): CSV · XLSX
Ticker Company Sector Trend F-Score Piotroski F-Score Criteria Watchlist
BIOCON.NS Biocon Ltd. Healthcare 6/9
6 of 9 criteria met
9 criteria
✓ Met Positive net income Net Profit 2026-03-31: ₹3,856,000,000 ProfitOrLossAttributableToOwnersOfParent (2026-03-31)
✓ Met Positive operating cash flow CFO 2026-03-31: ₹19,940,000,000 CashFlowsFromUsedInOperatingActivities (2026-03-31)
✗ Not met Return on assets improved YoY ROA 2025-03-31 → 2026-03-31: 1.72% → 0.61% Net Profit ÷ Total Assets, 2025-03-31 & 2026-03-31
✓ Met Operating cash flow exceeds net income CFO ₹19,940,000,000 vs Net Profit ₹3,856,000,000 (2026-03-31) CashFlowsFromUsedInOperatingActivities vs ProfitOrLossAttributableToOwnersOfParent (2026-03-31)
✓ Met Leverage (Debt/Assets) decreased YoY 2025-03-31 → 2026-03-31: 30.20% → 23.29% Total Debt ÷ Total Assets, 2025-03-31 & 2026-03-31
✓ Met Current ratio improved YoY 2025-03-31 → 2026-03-31: 1.14 → 1.22 Total Current Assets ÷ Total Current Liabilities, 2025-03-31 & 2026-03-31
✗ Not met No new shares issued Equity Share Capital 2025-03-31 → 2026-03-31: ₹6,003,000,000 → ₹8,105,000,000 EquityShareCapital, 2025-03-31 & 2026-03-31
✗ Not met Operating margin (EBIT/Revenue) improved YoY 2025-03-31 → 2026-03-31: 17.61% → 10.88% (ProfitBeforeExceptionalItemsAndTax + FinanceCosts) ÷ Revenue from Operations, 2025-03-31 & 2026-03-31
✓ Met Asset turnover improved YoY 2025-03-31 → 2026-03-31: 0.26 → 0.27 Revenue from Operations ÷ Total Assets, 2025-03-31 & 2026-03-31